SRTS
Income statement / Annual
Last year (2025), Sensus Healthcare Inc's total revenue was $27.48 M,
a decrease of 34.26% from the previous year.
In 2025, Sensus Healthcare Inc's net income was -$7.72 M.
See Sensus Healthcare Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$27.48 M |
$41.81 M |
$24.41 M |
$44.53 M |
$27.04 M |
$9.58 M |
$27.26 M |
$26.43 M |
$20.59 M |
$14.81 M |
| Cost of Revenue |
$15.62 M
|
$17.38 M
|
$10.35 M
|
$14.90 M
|
$10.05 M
|
$4.33 M
|
$9.71 M
|
$9.52 M
|
$6.79 M
|
$4.97 M
|
| Gross Profit |
$11.87 M
|
$24.43 M
|
$14.06 M
|
$29.63 M
|
$16.99 M
|
$5.25 M
|
$17.56 M
|
$16.91 M
|
$13.80 M
|
$9.85 M
|
| Gross Profit Ratio |
0.43
|
0.58
|
0.58
|
0.67
|
0.63
|
0.55
|
0.64
|
0.64
|
0.67
|
0.66
|
| Research and Development Expenses |
$7.78 M
|
$4.22 M
|
$3.68 M
|
$3.46 M
|
$3.44 M
|
$4.16 M
|
$6.42 M
|
$6.26 M
|
$5.49 M
|
$1.82 M
|
| General & Administrative Expenses |
$7.87 M
|
$7.15 M
|
$5.16 M
|
$5.01 M
|
$4.59 M
|
$3.99 M
|
$4.00 M
|
$4.12 M
|
$3.72 M
|
$3.47 M
|
| Selling & Marketing Expenses |
$6.52 M
|
$4.98 M
|
$5.61 M
|
$6.33 M
|
$4.84 M
|
$5.34 M
|
$9.10 M
|
$8.53 M
|
$8.31 M
|
$4.92 M
|
| Selling, General & Administrative Expenses |
$14.40 M
|
$12.13 M
|
$10.76 M
|
$11.34 M
|
$9.43 M
|
$9.33 M
|
$13.11 M
|
$12.66 M
|
$12.03 M
|
$8.38 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$22.17 M
|
$16.34 M
|
$14.44 M
|
$14.80 M
|
$12.87 M
|
$13.48 M
|
$19.53 M
|
$18.92 M
|
$17.52 M
|
$10.21 M
|
| Cost And Expenses |
$37.79 M
|
$33.72 M
|
$24.79 M
|
$29.70 M
|
$22.92 M
|
$17.81 M
|
$29.23 M
|
$28.43 M
|
$24.31 M
|
$15.17 M
|
| Interest Income |
$683.00 K
|
$932.00 K
|
$992.00 K
|
$382.00 K
|
$2.00 K
|
$66.00 K
|
$268.29 K
|
$139.28 K
|
$75.81 K
|
$38.54 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$2.00 K
|
$1.00 K
|
$14.00 K
|
$0.00
|
$156.69 K
|
$68.88 K
|
$21.87 K
|
| Depreciation & Amortization |
$386.00 K
|
$432.00 K
|
$461.00 K
|
$509.00 K
|
$613.00 K
|
$722.00 K
|
$545.72 K
|
$658.26 K
|
$387.92 K
|
$337.58 K
|
| EBITDA |
-$9.92 M |
$8.52 M |
$79.00 K |
$15.34 M |
$4.73 M |
-$6.10 M |
-$1.15 M |
-$1.21 M |
-$3.25 M |
$13.00 K |
| EBITDA Ratio |
-0.36
|
0.2
|
0
|
0.34
|
0.18
|
-0.64
|
-0.04
|
-0.05
|
-0.16
|
0
|
| Operating Income Ratio |
-0.38
|
0.19
|
-0.02
|
0.33
|
0.15
|
-0.86
|
-0.07
|
-0.08
|
-0.18
|
-0.02
|
| Total Other Income/Expenses Net |
$683.00 K
|
$932.00 K
|
$1.03 M
|
$13.16 M
|
-$1.00 K
|
$1.40 M
|
$268.29 K
|
-$17.41 K
|
$6.93 K
|
$16.67 K
|
| Income Before Tax |
-$9.62 M
|
$9.02 M
|
$652.00 K
|
$27.99 M
|
$4.12 M
|
-$6.84 M
|
-$1.70 M
|
-$2.02 M
|
-$3.71 M
|
-$346.45 K
|
| Income Before Tax Ratio |
-0.35
|
0.22
|
0.03
|
0.63
|
0.15
|
-0.71
|
-0.06
|
-0.08
|
-0.18
|
-0.02
|
| Income Tax Expense |
-$1.91 M
|
$2.38 M
|
$167.00 K
|
$3.75 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$7.72 M
|
$6.65 M
|
$485.00 K
|
$24.24 M
|
$4.12 M
|
-$6.84 M
|
-$1.70 M
|
-$2.02 M
|
-$3.71 M
|
-$346.45 K
|
| Net Income Ratio |
-0.28
|
0.16
|
0.02
|
0.54
|
0.15
|
-0.71
|
-0.06
|
-0.08
|
-0.18
|
-0.02
|
| EPS |
-0.47 |
0.41 |
0.0298 |
1.47 |
0.25 |
-0.42 |
-0.0711 |
-0.14 |
-0.28 |
-0.0288 |
| EPS Diluted |
-0.47 |
0.41 |
0.0298 |
1.46 |
0.25 |
-0.42 |
-0.0711 |
-0.14 |
-0.28 |
-0.0288 |
| Weighted Average Shares Out |
$16.33 M
|
$16.31 M
|
$16.26 M
|
$16.48 M
|
$16.48 M
|
$16.43 M
|
$16.23 M
|
$14.12 M
|
$13.24 M
|
$12.03 M
|
| Weighted Average Shares Out Diluted |
$16.33 M
|
$16.36 M
|
$16.27 M
|
$16.62 M
|
$16.50 M
|
$16.43 M
|
$16.23 M
|
$14.12 M
|
$13.24 M
|
$12.03 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
